EXECUTIVE CHAIR AGREEMENTExecutive Chair Agreement • March 23rd, 2023 • Solid Biosciences Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Executive Chair Agreement (together with Exhibit A, the “Agreement”), effective January 1, 2022 (the “Effective Date”), is by and between Ian F. Smith, an individual having an address at 45 Commonwealth Avenue, Unit 3, Boston, MA 02116 (the “Executive Chair”), and Solid Biosciences Inc., a Delaware corporation (together with its affiliates, the “Company”), having an address at 141 Portland Street, Fifth Floor, Cambridge, MA 02139.
BERRY PETROLEUM COMPANY, LLC EXECUTIVE CHAIR AGREEMENTExecutive Chair Agreement • November 30th, 2022 • Berry Corp (Bry) • Crude petroleum & natural gas • Texas
This Executive Chair Agreement (this “Agreement”) is made and entered into by and between Berry Petroleum Company, LLC, a Delaware limited liability company (the “Company”), and Arthur “Trem” Smith (“Executive”) entered into effective as of January 1, 2023 (the “Effective Date”). Executive and the Company are referred to individually as a “Party” and collectively as the “Parties.”
EXECUTIVE CHAIR AGREEMENTExecutive Chair Agreement • April 3rd, 2023 • Everi Holdings Inc. • Services-miscellaneous amusement & recreation • Nevada
THIS EXECUTIVE CHAIR AGREEMENT (the “Agreement”) is made and effective as of April 1, 2023 (the “Effective Date”) by and between Everi Payments Inc., a Delaware corporation (“EPI”) and wholly-owned subsidiary of Everi Holdings Inc., a Delaware corporation (“Everi Holdings”, and, together with EPI, the “Company”), and Michael Rumbolz (“Rumbolz” or the “Executive Chair”).
EXECUTIVE CHAIR AGREEMENTExecutive Chair Agreement • March 13th, 2024 • Solid Biosciences Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Executive Chair Agreement (together with Exhibit A, the “Agreement”), effective January 1, 2022 (the “Effective Date”), is by and between Ian F. Smith, an individual having an address at 45 Commonwealth Avenue, Unit 3, Boston, MA 02116 (the “Executive Chair”), and Solid Biosciences Inc., a Delaware corporation (together with its affiliates, the “Company”), having an address at 141 Portland Street, Fifth Floor, Cambridge, MA 02139.
EYENOVIA, INC. EXECUTIVE CHAIR AGREEMENTExecutive Chair Agreement • August 11th, 2022 • Eyenovia, Inc. • Pharmaceutical preparations • Delaware
THIS EXECUTIVE CHAIR AGREEMENT (the “Agreement”) is made and entered into as of August 1, 2022 (the “Effective Date”), by and between EYENOVIA, INC. (“Eyenovia” or “Company”), whose address is 295 Madison Ave, Suite 2400 – New York, NY 10017, and Dr. Sean Ianchulev (the “Advisor”), a resident of the state of New York. Eyenovia and the Advisor may be referred to herein individually as “Party” or collectively, as “Parties.”
EXECUTIVE CHAIR AGREEMENTExecutive Chair Agreement • October 29th, 2020 • CareDx, Inc. • Services-medical laboratories • California
This Executive Chair Agreement (this “Agreement”) is entered into by and between Peter K. Maag, Ph.D. (“Executive”) and CareDx, Inc., a Delaware corporation (the “Company”), effective as of November 1, 2020.
Solid Biosciences Inc. Executive Chairman AgreementExecutive Chair Agreement • March 14th, 2022 • Solid Biosciences Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Executive Chair Agreement (together with Exhibit A, the “Agreement”), effective January 1, 2022 (the “Effective Date”), is by and between Ian F. Smith, an individual having an address at 45 Commonwealth Avenue, Unit 3, Boston, MA 02116 (the “Executive Chair”), and Solid Biosciences Inc., a Delaware corporation (together with its affiliates, the “Company”), having an address at 141 Portland Street, Fifth Floor, Cambridge, MA 02139.
